Optimizing Combination Strategies for GPNMB-expressing Triple Negative Breast Cancers
Optimizing Combination Strategies for GPNMB-expressing Triple Negative Breast Cancers
批准号:
354630
负责人:
Siegel Peter M
金额:
$62.7万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2016
资助国家:
加拿大
项目状态:
已结题
起止时间:
2016-10-01 至 2021-10-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
BACKGROUND: Breast cancer can be sub-divided into distinct molecular subtypes, including triple negative breast cancer (TNBC), which is associated with the poorest patient outcomes. Unlike other breast cancer subtypes (luminal, Her2+ breast cancer) that h
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Defining the Immunomodulatory Role of GPNMB in Triple Negative Breast Cancer
-
批准号:468016
-
项目类别:Operating Grants
-
资助金额:$72.45万
-
财政年份:2022
-
负责人:Siegel Peter M
-
依托单位:
Identifying tumor-derived and microenvironmental factors that drive invasive growth of brain metastases
-
批准号:433618
-
项目类别:Operating Grants
-
资助金额:$75.24万
-
财政年份:2020
-
负责人:Siegel Peter M
-
依托单位:
Deciphering the multi-faceted roles of Afadin in breast cancer metastasis
-
批准号:433637
-
项目类别:Operating Grants
-
资助金额:$69.66万
-
财政年份:2020
-
负责人:Siegel Peter M
-
依托单位:
Metabolic Adaptations During Breast Cancer Metastasis
-
批准号:343339
-
项目类别:Operating Grants
-
资助金额:$61.26万
-
财政年份:2016
-
负责人:Siegel Peter M
-
依托单位:
Claudin-2 as a Prognostic and Therapeutic Target in Breast Cancer Liver Metastasis
-
批准号:304512
-
项目类别:Operating Grants
-
资助金额:$55.48万
-
财政年份:2014
-
负责人:Siegel Peter M
-
依托单位:
GPNMB as an emerging therapeutic target in metastatic breast cancer
-
批准号:237743
-
项目类别:Operating Grants
-
资助金额:$53.17万
-
财政年份:2011
-
负责人:Siegel Peter M
-
依托单位:
海外基金